“…Antihyperglycemic agents such as insulin, 10 metformin, thiazolidinediones, 26 and lipid-lowering therapies using statin, 27 fibrates, 28 and niacin 29 all have the potential to alter lipoprotein number, size, and distribution. HDL-mediated cholesterol efflux is also affected by insulin, 30 metformin, 31 and activators of the peroxisome proliferator-activated receptors. 32 In our study, most of our patients were on statins.…”